NCT03168984View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

August 14, 2017

Study Completion Date

August 14, 2017

Conditions
Healthy Japanese and Caucasian Subjects
Interventions
DRUG

UCB0942

"* Pharmaceutical form: Film-coated tablet~* Route of administration: Oral use"

OTHER

Placebo

"* Pharmaceutical form: Film-coated tablet~* Route of administration: Oral use"

Trial Locations (1)

Unknown

Up0039 001, London

All Listed Sponsors
lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT03168984 - A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects | Biotech Hunter | Biotech Hunter